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Abstract 
 
Background: Studies often ignore time-varying confounding or use inappropriate 
methodology to adjust for time-varying confounding.  
 
Aim: We estimated the effect of ICU-acquired bacteraemia on ICU mortality and discharge 
using appropriate methodology. 
 
Methods: Marginal structural models with inverse probability weighting were used to 
estimate the ICU mortality and discharge associated with ICU-acquired bacteraemia among 
patients who stayed more than 2 days at the general ICU of a London teaching hospital and 
remained bacteraemia-free during those first two days. For comparison, the same associations 
were evaluated with 1) a conventional Cox model, adjusting for only baseline confounders 
and 2) a Cox model adjusting for baseline and time-varying confounders. 
 
Findings: Using the marginal structural model with inverse probability weighting, 
bacteraemia was associated with an increase in ICU mortality (cause-specific hazard ratio 
[CSHR] 1.29, 95% CI 1.02-1.63) and a decrease in discharge (CSHR 0.52, 95% CI 0.45-
0.60). By 60 days, among patients still in the ICU after 2 days and without prior bacteraemia, 
8.0% of ICU-deaths could be prevented by preventing all ICU-acquired bacteraemia cases. 
The conventional Cox model adjusting for time-varying confounders gave substantially 
different results: CSHR 1.08 (95% CI 0.88-1.32) for ICU mortality and CSHR 0.68 (95% CI 
0.60-0.77) for discharge.  
 
Conclusion: In our study, even after adjusting for the timing of acquiring bacteraemia and 
time-varying confounding using inverse probability weighting for marginal structural models, 
ICU-acquired bacteraemia was associated with a decreased daily ICU discharge risk and an 
increased risk of ICU mortality.  
 
 
 
 
Keywords: burden; intensive care units; bacteraemia; inverse probability weighting; bias 
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Introduction 
Nosocomial bacteraemia is a potentially life-threatening condition that is estimated to affect 
240,000 people in Europe annually.1 Patients in intensive-care units (ICUs) are at particularly 
high risk of acquiring bacteraemia due to frequent invasive healthcare interventions.2  
 
Estimating the health impact and cost per case is essential to enable health economic 
evaluations comparing different interventions, determine cost-effective options and justified 
level of investment in control. There are a large number of studies that have estimated the 
potential impact of ICU-acquired bacteraemia on mortality and discharge.2-12 Nevertheless, 
the effect of ICU-acquired bacteraemia on mortality and length of stay is still uncertain.11 
Part of the variation in estimates can be explained by differences in case-mix, quality of care 
and antimicrobial resistance rates. However, there are also a number of methodological 
issues, which can impact estimates and are often overlooked. The fact that ICU-acquired 
infections have a time-dependent nature has often been ignored. For instance, comparisons of 
ever-infected versus never-infected patients ignore that patients need to survive long enough 
in order to acquire infection, thus giving an apparent survival benefit to the ever-infected 
patients.13 Time-dependent exposures can be modelled using time-dynamic models, such as 
time-dependent survival or multi-state models.13  
 
However, even when using time-dependent survival or multi-state models, assessment of the 
infection effect may be biased due to confounding by severity of illness. Adjusting for all 
confounders measured at the time of ICU admission may not be sufficient as patients who 
develop bacteraemia may deteriorate more prior to bacteraemia than patients who stay 
bacteraemia-free. The aforementioned techniques for time-dependent exposures fail to 
correctly adjust for such time-dependent confounding.14,15 They eliminate the effect of 
infection that is mediated through later severity of illness, thus potentially wiping out all of 
the infection’s effect. They moreover induce a so-called collider-stratification bias which may 
induce artificial correlations between infection and mortality, even in the absence of an effect 
(Appendix 1).16 To accommodate this, we will make use of inverse probability weighted 
methods for marginal structural models.17 
 
A further factor that may complicate interpretation occurs due to the fact that patients who 
stay longer in the ICU are at greater cumulative risk of death. For example, even if 
bacteraemia does not influence the daily risk of dying, one may still observe an apparent 
increase in cumulative mortality if infection increases length of stay. This issue can be solved 
by estimating the effect on the cumulative incidence of ICU death.18,19 
 
Aforementioned methodological challenges are rarely addressed simultaneously in published 
studies.3 We will add to the literature by simultaneously controlling for all 3 factors that 
complicate analysis: 1) the time-varying nature of the exposure; 2) potential time-varying 
confounding; 3) the presence of competing risks. We evaluate the effect of ICU-acquired 
bacteraemia on mortality and discharge using IPW under marginal structural models and 
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compare our results with estimates obtained using traditional regression methodology that 
ignores complicating factors.  
 
The UK government recently published its ambition to reduce the incidence of healthcare 
associated Gram-negative bacteraemia by 50% by 2020.20 It is important to quantify the 
health and economic burden of Gram-negatives to estimate justified levels of investment in 
their control, allowing cost-effectiveness evaluations of local and national interventions.  
Hence, we also evaluated the effect of bacteraemia involving Gram-negatives. 
 
Methods 
Electronic clinical records of all patients admitted to two general ICU wards at Guy’s and St 
Thomas’ hospitals, London between 2002 and 2006 were obtained.12,21  
We included all patients with an ICU length of stay of more than 2 days. From this cohort, we 
excluded patients with bacteraemia occurring during the first 2 days in the ICU as these were 
assumed not to be ICU-acquired.2-12 
 
The following variables were recorded at ICU admission: age, gender, type of admission 
(surgical or medical) and ICU ward. The Acute Physiology and Chronic Health Evaluation 
(APACHE) II score, administration of antibiotics, mechanical ventilation, central lines and 
renal replacement therapy were recorded on a daily basis during the entire ICU stay. All these 
variables were considered potential confounders based on clinical considerations and the 
literature.  
 
 
Marginal structural model with IPW 
Cause-specific hazard ratios (CSHRs) for ICU mortality and discharge were obtained using 
marginal structural Cox regression models, fitted using IPW to adequately take into account 
that the history of severity of illness may be different between patients who do and do not 
acquire bacteraemia. To adjust for confounders, a pseudo-population was constructed in 
which there was no longer confounding by the considered time-dependent variables. This was 
achieved by reweighting patients in the risk set (those who were still present in the ICU and 
were bacteraemia-free) on each day.17 Hence, by giving more weight to patients that do 
acquire bacteraemia on a specific day despite being unlikely to acquire bacteraemia given 
their history of severity of illness and vice versa, an artificial population is created in which 
the measured confounders (severity of illness) are independent of bacteraemia. The 
conditional probabilities used in the construction of the weights were set to 1 from the time of 
bacteraemia and onwards, and were otherwise estimated based on a pooled logistic regression 
model for the probability of acquiring bacteraemia in the ICU (Appendix 2).  
 
The obtained probabilities were used to generate daily patient-specific weights. When using 
these weights, the analysis can become heavily dependent on a single or few individuals who 
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acquire bacteraemia despite having a very low predicted probability to acquire bacteraemia or 
vice versa, thereby resulting in very large standard errors. To overcome this problem, 
stabilized weights multiplying the generated weights by the product of the conditional 
probability of the observed infection status before that day, as obtained from a similar pooled 
logistic regression model that included only baseline covariates; these same covariates were 
included in the marginal structural model.22  
 
The marginal structural models were fitted using weighted Cox regression with robust 
standard errors. To evaluate the effect of ICU-acquired bacteraemia we included a time-
varying binary indicator whether or not bacteraemia was acquired at or before the considered 
time, as well as the baseline covariates used for stabilization of the weights.21 The latter is 
necessary, because the stabilized weights create a pseudo-population in which there may still 
be confounding by the variables used for stabilization.22 
In the marginal structural model for ICU death (ICU discharge), the competing event ICU 
discharge (ICU death) was handled as a censoring event; resulting in CSHRs. The two 
separate cause-specific models for ICU discharge and ICU death were subsequently 
combined to evaluate, for each patient at each time, what is the cumulative incidence of ICU 
death in the absence of bacteraemia (R code in Appendix 3). By comparing this cumulative 
incidence with the observed incidence the number of ICU deaths that could be prevented was 
estimated. Our approach is different from multi-state approaches that ignore (time-dependent) 
confounding,23 and therefore less biased when such confounding is present.  
 
Although there were no missing values at baseline, in 3.8% of the following days missing 
values for the APACHE II score were imputed using the last observation carried forward.  
 
All models were built using R version 3.2.1 (packages “ipw”, “splines”, ”survival”).24 
 
Comparison with conventional Cox models 
In subsequent analyses we made a comparison with two commonly applied, but potentially 
biased, approaches: i) a Cox model ignoring potential confounding by risk-factors that 
change over the course of the ICU stay, thus only adjusting for base-line confounders; and ii) 
a Cox model regressing on baseline and time-varying factors (Appendix 4).  
 
Comparison of Gram negative and Gram positive bacteraemia.  
We also evaluated the effect of bacteraemia involving Gram-negatives. To obtain such 
estimates, without having to condition on a time-varying factor that is measured after the start 
of follow-up, we jointly modelled the probability of bacteraemia and the probability the 
bacteraemia involved Gram-negatives.  
To obtain the inverse probability weights for this analysis, the weights previously estimated 
for any bacteraemia were multiplied, from the time of acquiring bacteraemia onwards, by the 
stabilized inverse conditional probability that the bacteraemia involved Gram-negative 
bacteria, given the time-varying confounders on the previous day (Appendix 2). 
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The CSHR for ICU mortality and discharge were subsequently obtained using marginal 
structural Cox regression models. Compared to the analysis modelling ‘any bacteraemia’, an 
additional interaction between the indicator for bacteraemia and a binary indicator for the 
type of pathogen involved (Gram-negative set to 1) was incorporated. To obtain the effect of 
Gram-negative or Gram-positive bacteraemia these parameter estimates were combined and 
confidence intervals were calculated using the Delta method. 
To further investigate whether potential differences between bacteraemia caused by Gram-
negative or Gram-positive bacteria would be likely due to the inclusion of contaminated 
blood samples, particularly relevant for coagulase negative staphylococci,3 we further 
stratified the analyses for Gram-positive bacteria into three groups: Staphylococcus aureus, 
coagulase negative staphylococci (CNS) and other Gram-positives.  
 
Results 
Between 2002 and 2006, 2,914 patients were admitted to either ICU, contributing 3,159 ICU 
admissions. In 21.2% of admissions (n=671), a first blood culture positive for any bacteria 
was obtained from the patient more than 2 days after ICU admission. Of those ICU-acquired 
bacteraemia cases 218 (32.5%) involved Gram-negative bacteria, while 493 (73.5%) involved 
Gram-positive bacteria. 
The main isolated Gram-negative bacteria were Pseudomonas spp. (n=68), Escherichia coli 
(n=43), Enterobacter spp. (n=41), Klebsiella spp. (n=26) and Proteus spp. (n=17). Isolated 
Gram-positive bacteria were mainly coagulase negative staphylococci (n=370), S. aureus 
(n=69) and Enterococcus spp. (n=52). Median time from ICU admission to bacteraemia onset 
was 8 days (25th-75th percentile, 6-13). 
 
Baseline patient characteristics are shown in Table I. Patients acquiring bacteraemia were 
more frequently male and had a slightly higher APACHE II score at admission.  
 
 
Marginal structural model with IPW 
To adequately address time-varying confounding, we used marginal structural models fitted 
using IPW. ICU-acquired bacteraemia was associated with the daily risk of ICU mortality 
(CSHR 1.29; 95% CI 1.02-1.63) (Table II). More detailed descriptions of the models used for 
each component of the analysis are provided in Appendix 1. 
ICU-acquired bacteraemia was associated with a lower daily risk of ICU discharge (CSHR 
0.54; 95% CI 0.47-0.62).  
 
The inverse probability weights used in these marginal structural models had a median and 
mean of 0.99 and 1.01, an interquartile range and standard deviation of 0.14 and 0.31 (min 
0.26, max 4.49). These values raise no concern that our results might be negatively affected 
by extreme weights.25   
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The observed cumulative incidence of ICU death in the patient cohort and the expected 
cumulative incidence of ICU death if all ICU-acquired bacteraemia episodes would be 
prevented are shown in Figure 1. This figure indicates that by 60 days, among patients still in 
the ICU after 2 days and without prior bacteraemia, 8% of ICU-deaths could be prevented by 
preventing all ICU-acquired bacteraemia cases.  
 
Comparison with more conventional Cox models 
Using conventional Cox regression, ICU-acquired bacteraemia was associated with ICU 
mortality (CSHR 1.28; 95% CI, 1.04-1.57) and discharge (CSHR 0.51; 95% CI, 0.45-0.58) 
(Table II), suggesting that bacteraemia is associated with an increase in cumulative mortality 
not only because of a higher risk of death, but also because of longer lengths of stay.  
 
Conventional model with adjustment for time-dependent confounders 
When adjusting for time-dependent confounders using a conventional Cox model, the hazard 
ratio for ICU mortality was close to one (CSHR 1.08; 95% CI 0.88-1.32). Similarly, the 
hazard ratio for ICU discharge became weaker (CSHR 0.68; 95% CI 0.60-0.77) compared to 
the marginal structural model fitted using IPW.  
 
Comparison of Gram-negative and Gram-positive bacteraemia 
Gram-negative bacteraemia appeared to have a stronger effect on ICU mortality than 
bacteraemia involving only Gram-positive bacteria (CSHR 1.66; 95% CI 1.21-2.28 versus 
CSHR 1.15; 95% CI 0.84-1.58). Similarly, the association with daily ICU discharge rate was 
slightly stronger for ICU-acquired Gram-negative bacteraemia (CSHR 0.45; 95% CI 0.35-
0.57 versus CSHR 0.56; 95% CI 0.44-0.70). Although based on a limited number of cases, 
the analysis further stratifying Gram-positive bacteraemia cases suggested that S. aureus and 
‘other Gram-positives’ had a stronger association with ICU mortality than CNS (CSHR 1.35, 
95% CI 0.63-2.85 and CSHR 1.39, 95% CI 0.92-2.09 vs. CSHR 1.00, 95% CI 0.74-1.37). In 
contrast, S. aureus and other Gram-positives did not seem to have a stronger effect on ICU 
discharge than CNS (S. aureus CSHR: 0.65, 95% CI 0.48-0.87; CNS CSHR: 0.53, 95% CI 
0.45-0.63; other Gram-positives: 0.63, 95% CI 0.48-0.83).    
 
Discussion 
  
ICU acquired bacteraemia was associated with an increased ICU mortality risk (CSHR 1.29; 
95% CI 1.02-1.63) and a decreased daily ICU discharge risk (CSHR 0.54; 95% CI 0.47-0.62), 
even after adjusting for potential time-varying confounding and the time-dependent nature of 
the exposure. Our results suggest that ICU mortality could be noticeably lowered (in our 
study from 20.3% to 18.6% by 60 days) by preventing ICU-acquired bacteraemia.   
 
We applied various modelling strategies to our data that are applied in the literature. We 
illustrated that substantially different results can be obtained when conditioning on time-
varying factors instead of using techniques like marginal structural models with IPW. Using 
this former modelling strategy bias may be introduced due to adjustment for factors that are 
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likely affected by bacteraemia itself and due to collider stratification bias.15,17 Although the 
estimates obtained using the analysis completely ignoring time-varying confounding were 
very similar to the results obtained using the marginal structural model with IPW, this should 
not be assumed to always be the case without testing.3,17 Both simulation studies and studies 
using real data, including a recent study assessing the effect of ICU-acquired enterococcal 
bacteraemia, showed that marginal structural models with inverse probability weighting are 
often necessary to adjust for time-dependent confounders that are affected by 
exposure.3,14,17,26,27 For example, the effect of enterococcal bacteraemia was overestimated 
using a conventional Cox model only adjusting for baseline confounders.3       
 
Strengths and limitations 
An important strength of this study is that it is one of the first studies assessing the effects of 
ICU-acquired bacteraemia while addressing simultaneously the time-varying nature of this 
type of exposure, potential time-varying confounding and competing risks. One study has 
been published that used similar methodology to estimate cumulative mortality incidence 
associated with, specifically, enterococcal bacteraemia.3 Unfortunately, in our study, a 
separate estimate for enterococci resulted in very wide confidence intervals prohibiting a 
meaningful comparison.  
Time-varying confounders should not be modelled using conventional regression techniques 
that condition on time-varying factors that may be affected by exposure. Instead marginal 
structural models with IPW, such as applied in the current study, could be used. When 
extreme weights are generated, fitting marginal structural models via IPW is not reliable.22 In 
that regard, it is a pity that researchers often fail to report the distribution of the estimated 
weights including maximum and minimum values.3,25 The estimated weights in our study are 
not considered extreme weights.  
However, despite marginal structural models with IPW being able to adequately adjust for 
time-varying confounding, these techniques remain vulnerable to unmeasured confounding. 
Deterioration prior to acquiring bacteraemia may have been insufficiently captured by 
measuring the daily APACHE II score, administration of antibiotics, mechanical ventilation, 
central lines and renal replacement therapy. In a study that focused on the effect of ICU-
acquired enterococcal bacteraemia, using similar methodology, adjustment for time-varying 
sequential organ failure assessment (SOFA) score, prior antibiotic use and abdominal 
perforation or surgery resulted in more moderate effect estimates compared to a Cox model 
with adjustment for baseline confounders.3 Hence, in our study, the effect of ICU-acquired 
bacteraemia may have been overestimated.  
 
Some of the samples classified as bacteraemia may have actually been contaminated blood 
samples. Particularly, blood cultures positive for CNS may be contaminated blood samples, 
instead of true infections.3 The stronger associations observed for ICU-acquired Gram-
negative bacteraemia are therefore in line with expectations, although the difference between 
both groups could not be completely explained by the inclusion of CNS.  
Due to data limitations in records from recent years, we necessarily had to restrict our 
analysis to the years 2002–2006. Since then, the number of Gram-negative bacteraemia cases 
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resistant to the most widely used antibiotics has increased.28 Therefore, the current impact of 
ICU-acquired bacteraemia caused by Gram-negative bacteraemia may be even higher than 
the estimates in this study. Especially the impact on ICU discharge may have been 
underestimated, given the fact that a recent English study found that antibiotic resistance 
among E. coli increases length of stay, but did not seem to have a significant impact on in-
hospital mortality.29 
 
In our study, even after adjusting for the timing of acquiring bacteraemia and time-varying 
confounding using IPW for marginal structural models, ICU-acquired bacteraemia was 
associated with a substantial increased daily risk of ICU mortality and decreased daily ICU 
discharge risk.   
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Table I. Baseline patient characteristics and crude length of stay and mortality rates for 
admissions during which ICU-acquired bacteraemia developed vs. did not develop 
 Admissions during which 
bacteraemia developed 
(n=671) 
Admissions during which 
bacteraemia did not develop 
(n=2,488) 
Male sex, n (%) 434 (64.7) 1483 (59.6) 
Age, mean (SD) 61.8 (15.52) 60.8 (17.30) 
APACHE II, mean (SD) 19.1 (6.42) 18.0 (6.45) 
Admission type 
  Medicine, n (%) 
  Surgery, n (%) 
 
402 (59.9) 
269 (40.1) 
 
1521 (61.1) 
967 (38.9) 
ICU length of stay, median 
(Q1,Q3) 
21 (13, 34) 6 (4, 9) 
ICU mortality, n (%) 208 (31.0) 444 (17.8) 
Abbreviations:  ICU, intensive care unit; SD, standard deviation. 
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Table II. Association between ICU-acquired bacteraemia and ICU mortality and 
discharge. 
 ICU mortality CSHR 
(95% CI) 
ICU discharge 
CSHR (95% CI) 
Adjustment for baseline variables only 1.28 (1.04-1.57) 0.51 (0.45-0.58) 
Adjustment for baseline and time-varying 
variables using conventional Cox model 
1.08 (0.88-1.32) 0.68 (0.60-0.77) 
Adjustment for baseline and time-varying 
variables using marginal structural model with 
inverse probability weighting 
1.29 (1.02-1.63) 0.52 (0.45-0.60) 
Abbreviations: CI, confidence interval; CSHR, cause-specific hazard ratio; ICU, intensive 
care unit. 
 
 
 
    
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
15 
 
 
Figure 1. Observed intensive care unit (ICU) mortality vs expected ICU mortality 
without ICU-acquired bacteraemia. The solid line represents the observed ICU mortality in 
the patient cohort and the dashed line the expected mortality if all ICU-acquired bacteraemia 
in the same cohort would have been prevented. 
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Appendix 1. 
 
Example collider-stratification bias 
 
Collider-stratification bias is introduced by conditioning on a collider, a variable that is a 
common effect of two or more variables in a causal pathway.1 For example, consider the 
causal diagram presented in Figure A1. Suppose the value of the time-varying confounders at 
time t (Ct), e.g. a disease severity score like APACHE II or SOFA, is predicted by previous 
bacteraemia (Inft-1), but also predicts subsequent bacteraemia (Inft) and the risk of ICU death 
(Deatht). In that situation, Ct is a collider on the causal path from previous bacteraemia to 
ICU death through Ct (Inft-1 → Ct → Inft → Deatht). By conditioning on this collider (Ct), a 
spurious path will be opened from bacteraemia to ICU death, via the unmeasured common 
causes (U) of confounders and outcome (Inft → Ct → U → Deatht), hence, inducing collider-
stratification bias.3 In addition, conditioning on Ct will adjust away the (indirect) effect of 
previous bacteraemia (Inft-1) via later confounders (Ct), which are also intermediates, 
resulting in a biased estimate of the effect of bacteraemia on ICU death. While adjusting 
away the (indirect) effect of the exposure will attenuate the effect estimate, collider-
stratification bias may even result in effect estimates in the opposite direction of the true 
effect.1,2,3  
 
 
 
 
Figure A1. Directed acyclic graphs (DAGs) representing possible causal associations among time-varying 
potential confounders (C), bacteraemia (Inf), death and potentially unmeasured factors (U). t, current time; t-1 
previous time.  
 
References 
1. Greenland S. Quantifying biases in causal models: classical confounding vs collider-
stratification bias. Epidemiology. 2003;14:300-6. 
2. Whitcomb BW, Schisterman EF, Perkins NJ, Platt RW. Quantification of collider-
stratification bias and the birth weight paradox. Paediatr Perinat Epidemiol 
2009;23:394-402. 
3. Ali MS, Groenwold RHH, Pestman WR, Belitser SV, Hoes AW, de Boer A, Klungel 
OH. Time-dependent propensity score and collider-stratification bias: an example of 
beta2-agonist use and the risk of coronary heart disease. Eur J Epidemiol 
2013;28:291-299.  
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Appendix 2 
 
Model to create inverse probability weights: 
Daily probabilities of acquiring bacteraemia in the ICU were estimated using a pooled logistic 
regression model (logistic regression with each day within a patient treated as a separate 
observation). The final model was obtained by first adding main effects to the model and 
sequentially removing those that were nonsignificant at the 20% level. Non-linear effects were 
included in the model for the weights by using restricted cubic splines quadratic terms. We allowed 
for interactions between type of admission and APACHE II score at admission. Interactions and 
smoothing terms were added if significant at the 5% level.    
The following time-varying variables were included in the final model: the presence of central lines, 
mechanical ventilation, administration of antibiotics and the APACHE II score. Because time-varying 
variables measured on a given day may have been influenced by infection acquired on that day, only 
lagged values from the day before were included in the models. For the APACHE II score and 
antibiotic use we adjusted for lagged values 2 days before to acknowledge that the APACHE II score 
and antibiotic use within 24 hours before the onset of bacteremia are potentially surrogate markers 
for an infection that was incubating and hence may be affected by bacteremia on that day.  
To stabilize the weights the following variables were included: age, age-squared, gender, APACHE II 
score at admission, mechanical ventilation at admission and antibiotic administration at admission.  
Non-linear effects of time were included by using restricted cubic splines with four knots.  
The estimated inverse probability weights used in the marginal structural models had a median and 
mean of 0.99 and 1.01, an interquartile range and standard deviation of 0.14 and 0.31 (min 0.26, 
max 4.49).  
For the analysis estimating the effect of Gram-negative bacteraemia, the weights obtained above 
were multiplied, from the time of acquiring bacteraemia onwards, by the stabilized inverse 
conditional probability that the bacteraemia involved Gram-negative bacteria, given the time-
varying confounders on the previous day. These latter estimates were obtained using a logistic 
regression model. This model included the following time-varying variables: renal replacement 
therapy and the APACHE II score. For the APACHE II score we used lagged values from 2 days before, 
as done for the ‘any bacteraemia’ model. To stabilize the weights the ‘presence of central lines at 
admission’ was included. 
The final estimated inverse probability weights used for this analysis had a median and mean of 0.99 
and 1.01, an interquartile range and standard deviation of 0.13 and 0.31 (min 0.22, max 4.65).  
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Appendix 3 
 
R code used to obtain cumulative incidence function for ICU mortality  
The R code below was used to obtain the cumulative incidence function for mortality, by combining the results 
of the cause-specific hazards for ICU mortality and ICU discharge. This code adapts work by Therneau et al.
1
 on 
calculating cumulative incidences based on cause-specific hazards, to the context of Marginal Structural Cause-
specific Hazard Models.    
 
library(survival) 
 
# cause-specific model for ICU discharge 
cfit1 <- coxph(Surv(fuptime1, fuptime2, ICU_discharge) ~  
bacteraemia + Age + Sex + max_apache_score_admission + ventilated_admission + 
number_sys_antibiotic_admission + cluster(id), data=data, weights=IPWweight) 
 
# cause-specific model for ICU death 
cfit2 <- coxph(Surv(fuptime1, fuptime2, ICU_death) ~  
 bacteraemia + Age + Sex + max_apache_score_admission + central_lines_admission + 
 cluster(id), data=data, weights=IPWweight) 
 
# create a transition matrix 
temp <- matrix(list(),3,3) 
dimnames(temp) <- list(from=c("Alive","Discharge","Death"), 
                       to =c("Alive","Discharge","Death")) 
 
# create new data based on old data with bacteraemia set to 0 for all patients 
newdata <- data 
newdata$bacteraemia <- 0  
 
# get one line for each patient 
newdata <- newdata[unique(newdata$id),] 
 
# calculate the transition rates 
a <- survfit(cfit1, newdata, std.err=FALSE) 
b <- survfit(cfit2, newdata, std.err=FALSE) 
 
# populate the transition matrix 
temp[1,2] <- list(a) 
temp[1,3] <- list(b) 
 
# calculate the cumulative incidence function  
csurv <- survfit(temp,p0=c(1,0,0))  
 
# average over all patients to get marginal estimates for ICU mortality 
x <- csurv$time[1:89] 
d <- matrix(csurv$pstate[,3],ncol=89,byrow=T) 
d3<-apply(d,2,mean) 
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# plot the data for the first 60 days  
plot(stepfun(x,c(0,d3)),xlim=c(0,60),do.points=F, main="", xlab="Days in the ICU", ylab="Cumulative probability 
of ICU-mortality") 
 
References: 
1. Therneau T, Crowson C, Atkinson E. Multi-state models and competing risks. October 29, 2016. 
https://cran.r-project.org/web/packages/survival/vignettes/compete.pdf. Accessed January 30, 2017. 
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Appendix 4 
 
Table I. Association between ICU-acquired bacteraemia and ICU mortality estimated using 
marginal structural model with inverse probability weighting. 
 CSHR (95% confidence interval)c 
Bacteraemiaa 1.29 (1.02-1.63) 
Age (years) 1.01 (1.00-1.01) 
Genderb  0.83 (0.71-0.98) 
APACHE II score admission 1.08 (1.07-1.10) 
Central lines admission (yes/no) 1.23 (1.01-1.50) 
a 
Bacteraemia was coded as a time-varying variable that was 1 from the day bacteraemia was acquired and 
onwards and 0 otherwise.  
b 
Gender was coded as a binary variable with male gender set to 1. 
c Adjusted for the following time-varying variables using inverse probability weighting: the presence of central 
lines, mechanical ventilation, administration of antibiotics and the APACHE II score. 
 
 
Table II. Association between ICU-acquired bacteraemia and ICU mortality estimated using 
conventional Cox model adjusting for baseline and time-varying confounders. 
 CSHR (95% confidence interval) 
Bacteraemiaa 1.08 (0.88-1.32) 
Genderb 0.77 (0.66-0.91) 
Mechanical ventilation admission (yes/no) 0.80 (0.63-1.00) 
Time-varying variables  
Renal replacement therapy (yes/no) 1.66 (1.40-1.96) 
APACHE II score 1.25 (1.18-1.33) 
APACHE II score-squared 1.00 (1.00-1.00) 
Central lines (yes/no) 1.49 (1.17-1.90) 
Mechanical ventilation (yes/no) 1.83 (1.36-2.47) 
Number of systemic antibiotics 0.95 (0.89-1.01) 
a 
Bacteraemia was coded as a time-varying variable that was 1 from the day bacteraemia was acquired and 
onwards and 0 otherwise.  
b 
Gender was coded as a binary variable with male gender set to 1. 
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Table III. Association between ICU-acquired bacteraemia and ICU mortality estimated using 
conventional Cox model adjusting for baseline confounders. 
 CSHR (95% confidence interval) 
Bacteraemiaa 1.28 (1.04-1.57) 
Age (years) 1.01 (1.00-1.01) 
Genderb 0.79 (0.68-0.93) 
APACHE II score admission 1.16 (1.09-1.23) 
APACHE II score admission-squared 1.00 (1.00-1.00) 
Central lines admission (yes/no) 1.18 (0.98-1.42) 
a 
Bacteraemia was coded as a time-varying variable that was 1 from the day bacteraemia was acquired and 
onwards and 0 otherwise.  
b 
Gender was coded as a binary variable with male gender set to 1. 
 
 
Table IV. Association between ICU-acquired bacteraemia and ICU discharge estimated using 
marginal structural model with inverse probability weighting. 
 CSHR (95% confidence interval) * 
Bacteraemiaa 0.52 (0.45-0.60) 
Age (years) 1.00 (0.99-1.00) 
Genderb 1.10 (1.01-1.20) 
APACHE II score admission 0.95 (0.95-0.96) 
Mechanical ventilation 
admission (yes/no) 
0.71 (0.64-0.79) 
Number of systemic antibiotics 
admission 
0.91 (0.88-0.95) 
a 
Bacteraemia was coded as a time-varying variable that was 1 from the day bacteraemia was acquired and 
onwards and 0 otherwise.  
b 
Gender was coded as a binary variable with male gender set to 1. 
c Adjusted for the following time-varying variables using inverse probability weighting: the presence of central 
lines, mechanical ventilation, administration of antibiotics and the APACHE II score. 
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Table V. Association between ICU-acquired bacteraemia and ICU discharge estimated using 
conventional Cox model adjusting for baseline and time-varying confounders. 
 CSHR (95% confidence interval) 
Bacteraemiaa 0.68 (0.60-0.77) 
Genderb 1.08 (0.99-1.17) 
Central lines admission 1.26 (1.14-1.40) 
Mechanical ventilation 
admission (yes/no) 
1.83 (1.63-2.05) 
Renal replacement therapy 
admission (yes/no) 
1.29 (1.09-1.52) 
Number of systemic antibiotics 
admission 
0.93 (0.89-0.97) 
Time-varying variables  
Renal replacement therapy 
(yes/no) 
0.51 (0.44-0.60) 
APACHE II score 0.94 (0.93-0.94) 
Central lines (yes/no) 0.71 (0.64-0.78) 
Mechanical ventilation (yes/no) 0.18 (0.17-0.20) 
Number of systemic antibiotics 0.85 (0.81-0.88) 
a
Bacteraemia was coded as a time-varying variable that was 1 from the day bacteraemia was acquired and 
onwards and 0 otherwise.  
b
Gender was coded as a binary variable with male gender set to 1. 
 
 
 
 
Table VI. Association between ICU-acquired bacteraemia and ICU discharge estimated using 
conventional Cox model adjusting for baseline confounders. 
 CSHR (95% confidence interval) 
Bacteraemiaa 0.51 (0.45-0.58) 
Age (years) 1.00 (0.99-1.00) 
Genderb 1.12 (1.03-1.21) 
APACHE II score admission 0.95 (0.95-0.96) 
Mechanical ventilation 
admission (yes/no) 
0.69 (0.63-0.75) 
Number of systemic antibiotics 
admission 
0.91 (0.88-0.95) 
a
Bacteraemia was coded as a time-varying variable that was 1 from the day bacteraemia was acquired and 
onwards and 0 otherwise.  
b
Gender was coded as a binary variable with male gender set to 1. 
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